Other content in this Stream
Germline Modification for HIV Prevention is Unjustified
Daniel Kavanagh, PhD, responds to recent news of germline editing of human embryos in China.
Removing Barriers: Reimbursement and Compensation for Participation in Oncology Clinical Trials
The impact of participant payments on clinical trial recruitment.
WIRB Institutions Brochure
IRBs can make the most of central IRB partnerships
The IRB at Inova Health System of Falls Church, VA, began working with a central IRB 15 years ago. Since then, the IRB developed a well-organized process for its partnerships with independent IRBs.
Returning Study Results to Research Participants
Studies show clinical trial participants want to know what was learned from their involvement. Many sponsors are implementing plans to deliver plain language summaries to trial participants.
Written Procedures for IRBs: What Does the New Final Guidance from FDA and OHRP Mean to You?
WIRB 50: The Evolution of an IRB
Applied Clinical Trials:Single IRB Review for All Multicenter Clinical Trials
Pragmatic Clinical Trials: What You Need to Know
NIH Single IRB Review - Are You Ready
IRBs and IBCs: Critical Partners in Gene Research
Do the Right Thing: Unique Ethical Issues in Oncology Research
OhioHealth Case Study
Dissatisfied with its electronic IRB research management solution, OhioHealth Research & Innovation Institute searched for a solution to improve compliance, efficiency, customer service, and cost.
Interventional Clinical Trial or Registry Study? Writing Protocols that Demonstrate the Difference
WIRB 50: Celebrating 50 Years of Pioneering, Together
Fifty Years of Change: Henry K. Beecher and Protecting Human Subjects
In June of 1966, physician-researcher Henry K. Beecher published a paper entitled “Ethics and Clinical Research.” Explore the history and motivation that led to Dr. Beecher’s ground-breaking paper.
WIRB 50: The Gold Standard
A Discussion of the Revised Common Rule - Jan 2017
Investigational Drugs Outside of Clinical Trials - Understanding Expanded Access and Right-to-Try